companydata.dkcompanydata.dk

BIOSYM A/S: Financial statements 2015

CVR: 21774189

Source: annual report 2015, Danish Business Authority

01/07/2014 – 30/06/2015

BIOSYM A/S (CVR 21774189) has filed annual accounts for 2015. In 2015, the company reported a gross profit of DKK 7,639,343 and a net result of DKK 1,996,182 compared with DKK 1,531,251 the year before. That is an increase of 24.7% compared with the year before. Equity in the 2015 report amounted to DKK 9,552,767. The solvency ratio was 48.8%.

Gross Profit
DKK 7,639,343
Profit/Loss
DKK 1,996,182
Equity
DKK 9,552,767
Total Assets
DKK 19,569,556

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2015-7.6 mio.2 mio.9.6 mio.-
2014-6.1 mio.1.5 mio.7.6 mio.-
2013--4.7 mio.555 t.-6 mio.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is BIOSYM A/S?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

About BIOSYM A/S

BIOSYM A/S is a Danish company of the type Aktieselskab based in Ikast, founded in 1999. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Sanne Biisgaard. The board consists of Kati Marika Rajala (chair), Elina Liisa Maarit Haavisto and Janne Vertanen. The company is owned by Oy Verman Ab. The company has 19 employees (2026). In 2025, the company reported a gross profit of DKK 23,552,721 and a net result of DKK 8,530,373 compared with DKK 3,810,817 the year before. Equity in the 2025 report amounted to DKK 46,311,564.

Source: annual report 2025, Danish Business Authority